![](/img/cover-not-exists.png)
Targeting the proteasome-associated deubiquitinating enzyme USP14 impairs melanoma cell survival and overcomes resistance to MAPK-targeting therapies
Didier, Robin, Mallavialle, Aude, Ben Jouira, Rania, Domdom, Marie Angela, Tichet, Mélanie, Auberger, Patrick, Luciano, Frédéric, Ohanna, Mickael, Tartare-Deckert, Sophie, Deckert, MarcelLanguage:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-17-0919
Date:
April, 2018
File:
PDF, 3.10 MB
english, 2018